Abiomed had a rough 2019, and their stock declined substantially because of it. The FDA warned that Abiomed's flagship product had an "increased rate of mortality", which stunted their revenue growth and collapsed their stock price. Instead of fighting the FDA, Abiomed worked with them to determine how these increased mortality rates occurred. Later in 2019, they confirmed … [Read more...] about Abiomed’s Heart Could Be In The Right Place
Recent Investments
What If iRobot Became the Apple of Robotics?
iRobot stock is down over 66% since April 2019, primarily due to higher China tariffs and more copycats entering the robotic vacuum market. They're managing these problems by diversifying their supply chain and litigating their patent disputes against copycats. In the meantime, iRobot has over 70% global market share in robotic vacuums, a solid product pipeline, and over … [Read more...] about What If iRobot Became the Apple of Robotics?
Pluralsight Could Corner The Technology Skills Market
Pluralsight announced a massive billings slowdown in their August 2019 earnings report, and the market cut their stock valuation in half from $4.7 billion to $2.2 billion. With the best in class product and growing wallet spend, I believe Pluralsight will regain their momentum once they hire and train more salespeople. While there's no telling when they will turn around, I … [Read more...] about Pluralsight Could Corner The Technology Skills Market